{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T12:50:52Z","timestamp":1776862252141,"version":"3.51.2"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"HIV-NAT, Thai Red Cross AIDS Research Centre"},{"name":"Center of Excellence in Tuberculosis, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"},{"name":"Faculty of Science, Department of Health Sciences, Vrije Universiteit, Amsterdam Public Health Research Institute, Amsterdam, Netherlands"},{"name":"Department of Global Health, Academic Medical Center, Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, Netherlands"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Antiretroviral therapy (ART) is known to reduce tuberculosis (TB) incidence among people living with HIV (PLWH). However, studies describing the impact of long-term ART and CD4 count recovery on TB incidence remain scarce due to limited follow up in previous studies. We evaluated TB incidence in a long-term cohort of PLWH on ART in Thailand.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted an analysis of PLWH aged\u2009\u2265\u200918\u00a0years who started ART between 1996 and December 2020. Participants were followed up every 6\u00a0months for routine HIV care. TB risk factors, body mass index (BMI), physical examination and full differential blood counts were evaluated at each clinic visit, and CD4 cell counts and HIV RNA every 12\u00a0months. Participants diagnosed with TB\u2009&gt;\u20093\u00a0months after starting ART were classified as incident cases. Time to event models with death as a competing risk, were used to derive the TB cumulative incidence function (CIF) after ART initiation, and assess time-updated factors associated with incident TB using a six month lag.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 2,636 PLWH contributing 24,229 person years (PY) of follow-up on ART were analysed. Median age was 32.0 (IQR 27.4\u201337.6) years; 67.5% were male. Median CD4 cell count at ART initiation was 264 (IQR 167\u2013379) cells\/mm<jats:sup>3<\/jats:sup> and median follow-up duration was 7.6 (IQR 1.9\u201315.7) years. During follow-up, 113 PLWH developed TB. The probability of incident TB was 0.7%, 1.7%, 3.3% and 4.3%, at 1, 2, 5 and 7\u00a0years after ART initiation, respectively. TB CIF was highest among participants with CD4\u2009&lt;\u200950 cells\/mm<jats:sup>3<\/jats:sup>. The overall crude incidence of TB was 4.66 (95% CI 3.87\u20135.60) per 1000 PY. Low CD4 count, BMI\u2009&lt;\u200918\u00a0kg\/m<jats:sup>2<\/jats:sup>, and substance use in the previous six months were significantly associated with incident TB. Incidence declined with time on suppressive ART, but remained higher than the Thai general population 7\u00a0years after ART initiation (2.2 vs 1.5\/1000 PY, respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Despite a marked reduction in TB incidence following ART, ongoing TB risk remains high among PLWH, despite long-term suppressive ART. Those with low CD4 cell counts, who are underweight, or currently having substance abuse should be carefully monitored.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07332-3","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T03:56:47Z","timestamp":1649303807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Incidence and factors associated with active tuberculosis among people living with HIV after long-term antiretroviral therapy in Thailand: a competing risk model"],"prefix":"10.1186","volume":"22","author":[{"given":"Sivaporn","family":"Gatechompol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiratchaya","family":"Sophonphan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasiwimol","family":"Ubolyam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anchalee","family":"Avihingsanon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"van Leth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Cobelens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"issue":"9377","key":"7332_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0140-6736(03)13802-0","volume":"362","author":"A Mocroft","year":"2003","unstructured":"Mocroft A, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet. 2003;362(9377):22\u20139.","journal-title":"Lancet"},{"issue":"6","key":"7332_CR2","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1086\/423183","volume":"39","author":"KH Wong","year":"2004","unstructured":"Wong KH, Chan KC, Lee SS. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy. Clin Infect Dis. 2004;39(6):853\u201360.","journal-title":"Clin Infect Dis"},{"key":"7332_CR3","unstructured":"World Health Organization. Global tuberculosis report 2020. Geneva, Switzerland. 2020. https:\/\/www.who.int\/publications\/i\/item\/9789240013131. accessed 1 April 2021."},{"issue":"1","key":"7332_CR4","doi-asserted-by":"publisher","first-page":"19251","DOI":"10.7448\/IAS.17.1.19251","volume":"17","author":"G Alvarez-Uria","year":"2014","unstructured":"Alvarez-Uria G, et al. Incidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India. J Int AIDS Soc. 2014;17(1):19251.","journal-title":"J Int AIDS Soc"},{"issue":"9323","key":"7332_CR5","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","volume":"359","author":"M Badri","year":"2002","unstructured":"Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet. 2002;359(9323):2059\u201364.","journal-title":"Lancet"},{"issue":"7","key":"7332_CR6","doi-asserted-by":"publisher","first-page":"e1001270","DOI":"10.1371\/journal.pmed.1001270","volume":"9","author":"AB Suthar","year":"2012","unstructured":"Suthar AB, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med. 2012;9(7):e1001270.","journal-title":"PLoS Med"},{"issue":"7","key":"7332_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1473-3099(10)70078-5","volume":"10","author":"SD Lawn","year":"2010","unstructured":"Lawn SD, et al. Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. Lancet Infect Dis. 2010;10(7):489\u201398.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"7332_CR8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/QAI.0000000000000060","volume":"65","author":"K Naidoo","year":"2014","unstructured":"Naidoo K, et al. High rates of tuberculosis in patients accessing HAART in rural South Africa. J Acquir Immune Defic Syndr. 2014;65(4):438\u201346.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"7332_CR9","doi-asserted-by":"publisher","first-page":"e111209","DOI":"10.1371\/journal.pone.0111209","volume":"9","author":"T Kufa","year":"2014","unstructured":"Kufa T, et al. Incidence of HIV-associated tuberculosis among individuals taking combination antiretroviral therapy: a systematic review and meta-analysis. PLoS ONE. 2014;9(11):e111209.","journal-title":"PLoS ONE"},{"key":"7332_CR10","unstructured":"World Health Organization. Tuberculosis profile: Thailand. Geneva, Switzerland. 2020. https:\/\/worldhealthorg.shinyapps.io\/tb_profiles\/?_inputs_&entity_type=%22country%22&lan=%22EN%22&iso2=%22TH%22. accessed 25 Aug 2021."},{"key":"7332_CR11","unstructured":"Thailand National Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2010. 2010. https:\/\/www.who.int\/hiv\/pub\/guidelines\/thailand_art.pdf."},{"key":"7332_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12981-015-0053-z","volume":"12","author":"W Manosuthi","year":"2015","unstructured":"Manosuthi W, et al. Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand. AIDS Res Ther. 2015;12:12.","journal-title":"AIDS Res Ther"},{"key":"7332_CR13","unstructured":"Thailand National Guidelines on HIV\/AIDS Treatment and Prevention 2017. 2017. http:\/\/www.thaiaidssociety.org\/images\/PDF\/hiv_thai_guideline_2560.pdf."},{"key":"7332_CR14","unstructured":"Thailand National Guidelines on HIV\/AIDS Diagnosis,Treatment and Prevention 2020\/ 2021. 2021. http:\/\/www.thaiaidssociety.org\/images\/PDF\/thai_aids_guidelines_2020_2021.pdf."},{"key":"7332_CR15","unstructured":"National Tuberculosis Control Programme Guideline, Thailand, 2013. 2013. https:\/\/www.tbthailand.org\/download\/\u0e41\u0e19\u0e27\u0e17\u0e32\u0e07\u0e01\u0e32\u0e23\u0e14\u0e33\u0e40\u0e19\u0e34\u0e19\u0e07\u0e32\u0e19_2556-2.pdf. ."},{"key":"7332_CR16","unstructured":"National Tuberculosis Control Programme Guideline, Thailand, 2018. 2018. https:\/\/www.tbthailand.org\/download\/Manual\/NTP2018.pdf."},{"issue":"446","key":"7332_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496\u2013509.","journal-title":"J Am Stat Assoc"},{"key":"7332_CR18","unstructured":"World Health Organization. Regional Office for the Western P. The Asia-Pacific perspective : redefining obesity and its treatment. Sydney : Health Communications Australia, 2000."},{"issue":"4","key":"7332_CR19","doi-asserted-by":"publisher","first-page":"e25240","DOI":"10.1002\/jia2.25240","volume":"22","author":"H Tweya","year":"2019","unstructured":"Tweya H, et al. The shift in tuberculosis timing among people living with HIV in the course of antiretroviral therapy scale-up in Malawi. J Int AIDS Soc. 2019;22(4):e25240.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"7332_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s41182-020-00264-1","volume":"48","author":"M Majigo","year":"2020","unstructured":"Majigo M, et al. Prevalence and incidence rate of tuberculosis among HIV-infected patients enrolled in HIV care, treatment, and support program in mainland Tanzania. Trop Med Health. 2020;48(1):76.","journal-title":"Trop Med Health"},{"issue":"1","key":"7332_CR21","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1186\/s12879-019-4361-0","volume":"19","author":"A Dravid","year":"2019","unstructured":"Dravid A, et al. Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India. BMC Infect Dis. 2019;19(1):714.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"7332_CR22","doi-asserted-by":"publisher","first-page":"e34156","DOI":"10.1371\/journal.pone.0034156","volume":"7","author":"A Gupta","year":"2012","unstructured":"Gupta A, et al. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PLoS ONE. 2012;7(3):e34156.","journal-title":"PLoS ONE"},{"issue":"4","key":"7332_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/QAI.0b013e3181f9fb39","volume":"56","author":"A Van Rie","year":"2011","unstructured":"Van Rie A, Westreich D, Sanne I. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies. JAIDS J Acquir Immune Defic Syndr. 2011;56(4):349\u201355.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"1","key":"7332_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41182-021-00306-2","volume":"49","author":"MM Azanaw","year":"2021","unstructured":"Azanaw MM, et al. Incidence and predictors of tuberculosis among HIV patients after initiation of antiretroviral treatment in Ethiopia: a systematic review and meta-analysis. Trop Med Health. 2021;49(1):18.","journal-title":"Trop Med Health"},{"issue":"13","key":"7332_CR25","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1097\/QAD.0b013e32832d3b6d","volume":"23","author":"SD Lawn","year":"2009","unstructured":"Lawn SD, et al. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS. 2009;23(13):1717\u201325.","journal-title":"AIDS"},{"key":"7332_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1742-6405-10-18","volume":"10","author":"D Kassa","year":"2013","unstructured":"Kassa D, et al. Virologic and immunologic outcome of HAART in Human Immunodeficiency Virus (HIV)-1 infected patients with and without tuberculosis (TB) and latent TB infection (LTBI) in Addis Ababa, Ethiopia. AIDS Res Ther. 2013;10:18.","journal-title":"AIDS Res Ther"},{"issue":"4","key":"7332_CR27","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jinf.2013.11.016","volume":"68","author":"DC Hsu","year":"2014","unstructured":"Hsu DC, et al. Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy. J Infect. 2014;68(4):344\u201354.","journal-title":"J Infect"},{"issue":"11","key":"7332_CR28","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1097\/QAD.0000000000000705","volume":"29","author":"E Liu","year":"2015","unstructured":"Liu E, et al. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy. AIDS. 2015;29(11):1391\u20139.","journal-title":"AIDS"},{"issue":"2","key":"7332_CR29","doi-asserted-by":"publisher","first-page":"e016961","DOI":"10.1136\/bmjopen-2017-016961","volume":"8","author":"A Ahmed","year":"2018","unstructured":"Ahmed A, et al. Incidence and determinants of tuberculosis infection among adult patients with HIV attending HIV care in north-east Ethiopia: a retrospective cohort study. BMJ Open. 2018;8(2):e016961.","journal-title":"BMJ Open"},{"key":"7332_CR30","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12879-016-1598-8","volume":"16","author":"T Kufa","year":"2016","unstructured":"Kufa T, et al. The incidence of tuberculosis among hiv-positive individuals with high CD4 counts: implications for policy. BMC Infect Dis. 2016;16:266.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"7332_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/ije\/dyp308","volume":"39","author":"K L\u00f6nnroth","year":"2010","unstructured":"L\u00f6nnroth K, et al. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol. 2010;39(1):149\u201355.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"7332_CR32","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/cid\/cix852","volume":"66","author":"HH Lin","year":"2018","unstructured":"Lin HH, et al. Association of obesity, diabetes, and risk of tuberculosis: two population-based cohorts. Clin Infect Dis. 2018;66(5):699\u2013705.","journal-title":"Clin Infect Dis"},{"key":"7332_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12916-015-0381-9","volume":"13","author":"L Pealing","year":"2015","unstructured":"Pealing L, et al. Risk of tuberculosis in patients with diabetes: population based cohort study using the UK Clinical Practice Research Datalink. BMC Med. 2015;13:135.","journal-title":"BMC Med"},{"issue":"12","key":"7332_CR34","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/archinte.167.12.1297","volume":"167","author":"CC Leung","year":"2007","unstructured":"Leung CC, et al. Lower risk of tuberculosis in obesity. Arch Intern Med. 2007;167(12):1297\u2013304.","journal-title":"Arch Intern Med"},{"issue":"4","key":"7332_CR35","doi-asserted-by":"publisher","first-page":"e0195104","DOI":"10.1371\/journal.pone.0195104","volume":"13","author":"SJ Kim","year":"2018","unstructured":"Kim SJ, et al. Association of body mass index with incident tuberculosis in Korea. PLoS ONE. 2018;13(4):e0195104.","journal-title":"PLoS ONE"},{"issue":"10","key":"7332_CR36","doi-asserted-by":"publisher","first-page":"e1006676","DOI":"10.1371\/journal.ppat.1006676","volume":"13","author":"M Beigier-Bompadre","year":"2017","unstructured":"Beigier-Bompadre M, et al. Mycobacterium tuberculosis infection modulates adipose tissue biology. PLoS Pathog. 2017;13(10):e1006676.","journal-title":"PLoS Pathog"},{"key":"7332_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.micpath.2016.01.004","volume":"93","author":"P Agarwal","year":"2016","unstructured":"Agarwal P, et al. Mycobacterium tuberculosis can gain access to adipose depots of mice infected via the intra-nasal route and to lungs of mice with an infected subcutaneous fat implant. Microb Pathog. 2016;93:32\u20137.","journal-title":"Microb Pathog"},{"issue":"2","key":"7332_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.02771-18","volume":"10","author":"JP Ayyappan","year":"2019","unstructured":"Ayyappan JP, et al. Adipose tissue regulates pulmonary pathology during TB infection. MBio. 2019;10(2):1\u20137.","journal-title":"MBio"},{"issue":"3","key":"7332_CR39","first-page":"318","volume":"14","author":"M Demb\u00e9l\u00e9","year":"2010","unstructured":"Demb\u00e9l\u00e9 M, et al. Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso. Int J Tuberc Lung Dis. 2010;14(3):318\u201323.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"7332_CR40","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1097\/QAD.0b013e32833a2a4a","volume":"24","author":"CF Hanrahan","year":"2010","unstructured":"Hanrahan CF, et al. Body mass index and risk of tuberculosis and death. AIDS. 2010;24(10):1501\u20138.","journal-title":"AIDS"},{"issue":"4","key":"7332_CR41","doi-asserted-by":"publisher","first-page":"e35948","DOI":"10.1371\/journal.pone.0035948","volume":"7","author":"L Benova","year":"2012","unstructured":"Benova L, et al. Association of BMI category change with TB treatment mortality in HIV-positive smear-negative and extrapulmonary TB patients in Myanmar and Zimbabwe. PLoS ONE. 2012;7(4):e35948.","journal-title":"PLoS ONE"},{"issue":"1","key":"7332_CR42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40249-018-0418-3","volume":"7","author":"K Naidoo","year":"2018","unstructured":"Naidoo K, Yende-Zuma N, Augustine S. A retrospective cohort study of body mass index and survival in HIV infected patients with and without TB co-infection. Infect Dis Poverty. 2018;7(1):35.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"7332_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/jech.54.1.64","volume":"54","author":"ST Keizer","year":"2000","unstructured":"Keizer ST, et al. How does tuberculosis relate to HIV positive and HIV negative drug users? J Epidemiol Community Health. 2000;54(1):64\u20138.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"7332_CR44","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1086\/594126","volume":"48","author":"RG Deiss","year":"2009","unstructured":"Deiss RG, Rodwell TC, Garfein RS. Tuberculosis and illicit drug use: review and update. Clin Infect Dis. 2009;48(1):72\u201382.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"7332_CR45","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1128\/CMR.16.2.209-219.2003","volume":"16","author":"H Friedman","year":"2003","unstructured":"Friedman H, Newton C, Klein TW. Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev. 2003;16(2):209\u201319.","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"7332_CR46","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1086\/433175","volume":"41","author":"F Kapadia","year":"2005","unstructured":"Kapadia F, et al. The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. Clin Infect Dis. 2005;41(7):1027\u201334.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"7332_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.idc.2007.03.009","volume":"21","author":"RD Bruce","year":"2007","unstructured":"Bruce RD, Altice FL. Clinical care of the HIV-infected drug user. Infect Dis Clin N Am. 2007;21(1):149\u201379.","journal-title":"Infect Dis Clin N Am"},{"issue":"11","key":"7332_CR48","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/sim.2712","volume":"26","author":"H Putter","year":"2007","unstructured":"Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26(11):2389\u2013430.","journal-title":"Stat Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07332-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07332-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07332-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T03:57:15Z","timestamp":1649303835000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07332-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7332"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07332-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,7]]},"assertion":[{"value":"28 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the medical ethics committee, Faculty of Medicine, Chulalongkorn University, Bangkok. This study was conducted according to Declaration of Helsinki and Good Clinical Practice. All participants provided signed written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"346"}}